Actively Recruiting
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
Led by Rigshospitalet, Denmark · Updated on 2023-12-13
100
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
Sponsors
R
Rigshospitalet, Denmark
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size \>4 cm, multifocal tumors and local recurrences.
CONDITIONS
Official Title
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with vulva cancer, tumor > 4 cm, multifocal tumor, or local recurrences in vulva
You will not qualify if you...
- Previous external irradiation of the vulva or groins
- Former sentinel node or inguinal lymphadenectomy in the relevant groin
- Known allergy to ICG or iodine
- Patient is in active treatment for other cancer and/or disseminated disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Copenhagen University Hospital
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
L
Ligita P Frøding
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here